Journal
CLINICAL AND VACCINE IMMUNOLOGY
Volume 17, Issue 5, Pages 882-883Publisher
AMER SOC MICROBIOLOGY
DOI: 10.1128/CVI.00038-10
Keywords
-
Categories
Ask authors/readers for more resources
The plasmatic levels of 1,3-beta-D-glucan (BDG) were >523 mu g/ml in 4 children, 2 low-birth-weight neonates and 2 stem cell transplant recipients, with the following invasive fungal diseases (IFD) proven apart from this BDG test: 3 cases of Candida parapsilosis candidemias and 1 case of disseminated aspergillosis. The BDG test may be useful for identification of IFD in pediatrics.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available